Evidence map›Paper›PMID 25114104›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

MyD88 signaling inhibits protective immunity to the gastrointestinal helminth parasite Heligmosomoides polygyrus.

Lisa A Reynolds, Yvonne Harcus, Katherine A Smith, Lauren M Webb, James P Hewitson, Ewan A Ross, Sheila Brown, Satoshi Uematsu, Shizuo Akira, David Gray and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Infection and immunity · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Analysis of gene-environment interactions in postnatal development of the mammalian intestine.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Lisa A ReynoldsInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
Yvonne HarcusInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
Katherine A SmithInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
Lauren M WebbInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
James P HewitsonInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
Ewan A RossMedical Research Council Centre for Immune Regulation, Institute of Microbiology and Infection, School of Immunity and Infection, University of Birmingham, Birmingham, B15 2TT, United Kingdom;
Sheila BrownInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
Satoshi UematsuDivision of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, The University of Tokyo, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan;
Shizuo AkiraDepartment of Host Defense, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan; and Laboratory of Host Defense, World Premier Institute Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
David GrayInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
Mohini GrayInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
Andrew S MacDonaldInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom;
Adam F CunninghamMedical Research Council Centre for Immune Regulation, Institute of Microbiology and Infection, School of Immunity and Infection, University of Birmingham, Birmingham, B15 2TT, United Kingdom;
Rick M MaizelsInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom; r.maizels@ed.ac.uk.
University of Edinburgh · GBCentre for Immunity, Infection and Evolution · GBImmune Regulation (United Kingdom) · GBMedical Research Council · GBOsaka International University · JPThe University of Tokyo · JP

Funding

Biotechnology and Biological Sciences Research Council BB/F022778/1Biotechnology and Biological Sciences Research Council BB/L009986/1Medical Research Council G0701437Medical Research Council MR/J009555/1Versus Arthritis 20035Wellcome Trust 086629Wellcome Trust 090281Wellcome Trust 095831
6 · The paper itself

Abstract

Helminth parasites remain one of the most common causes of infections worldwide, yet little is still known about the immune signaling pathways that control their expulsion. C57BL/6 mice are chronically susceptible to infection with the gastrointestinal helminth parasite Heligmosomoides polygyrus. In this article, we report that C57BL/6 mice lacking the adapter protein MyD88, which mediates signaling by TLRs and IL-1 family members, showed enhanced immunity to H. polygyrus infection. Alongside increased parasite expulsion, MyD88-deficient mice showed heightened IL-4 and IL-17A production from mesenteric lymph node CD4(+) cells. In addition, MyD88(-/-) mice developed substantial numbers of intestinal granulomas around the site of infection, which were not seen in MyD88-sufficient C57BL/6 mice, nor when signaling through the adapter protein TRIF (TIR domain-containing adapter-inducing IFN-β adapter protein) was also ablated. Mice deficient solely in TLR2, TLR4, TLR5, or TLR9 did not show enhanced parasite expulsion, suggesting that these TLRs signal redundantly to maintain H. polygyrus susceptibility in wild-type mice. To further investigate signaling pathways that are MyD88 dependent, we infected IL-1R1(-/-) mice with H. polygyrus. This genotype displayed heightened granuloma numbers compared with wild-type mice, but without increased parasite expulsion. Thus, the IL-1R-MyD88 pathway is implicated in inhibiting granuloma formation; however, protective immunity in MyD88-deficient mice appears to be granuloma independent. Like IL-1R1(-/-) and MyD88(-/-) mice, animals lacking signaling through the type 1 IFN receptor (i.e., IFNAR1(-/-)) also developed intestinal granulomas. Hence, IL-1R1, MyD88, and type 1 IFN receptor signaling may provide pathways to impede granuloma formation in vivo, but additional MyD88-mediated signals are associated with inhibition of protective immunity in susceptible C57BL/6 mice.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsCD4-Positive T-LymphocytesGranulomaInterleukin-17Interleukin-4MiceMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88Nematospiroides dubiusReceptor, Interferon alpha-betaReceptors, Interleukin-1 Type ISignal TransductionStrongylida InfectionsToll-Like Receptor 2Adaptor Proteins, Vesicular TransportIfnar1 protein, mouseIL1R1 protein, mouseInterleukin-17Interleukin-4Myd88 protein, mouseMyeloid Differentiation Factor 88Receptor, Interferon alpha-betaReceptors, Interleukin-1 Type ITicam1 protein, mouseTlr2 protein, mouseTlr4 protein, mouseTlr9 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 5Toll-Like Receptor 9

Identifiers

PMID25114104
PMCPMC4157852
OpenAlexW2117317247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.